Funded Startups in Basel-Stadt
Basel-Stadt’s most recent disclosed rounds show a wide funding spread: Windward Bio’s $165M (2026-05-04) is far above the next-largest disclosed amounts in…
Basel-Stadt’s most recent disclosed rounds show a wide funding spread: Windward Bio’s $165M (2026-05-04) is far above the next-largest disclosed amounts in the list, including Nuclidium’s $34M (2026-05-28) and Granite Bio’s $70M (2025-04-24). The only company above $100M in disclosed amounts is Windward Bio, while several other large rounds (e.g., Noema Pharma $147M on 2024-12-11; VectivBio $125M on 2022-10-13; Moonlight AI $3M on 2026-05-06) sit well below that top-end edge.
Timing clusters strongly in the newest window: 2026 entries run from 2026-02-17 (Axmed $6M) through 2026-06-11 (ClearideBio Therapeutics, undisclosed), with 2026 accounting for most of the 43 rows shown. Sector clustering is also pronounced, with Biotechnology present in more than half the entries (e.g., ClearideBio Therapeutics, Nuclidium, Windward Bio, Granite Bio, Noema Pharma), alongside multiple “Series Unknown”/blank round classifications and six “undisclosed” amounts spread across later-stage and early-stage labels.
Most recent rounds
43 shownRelated listings
Frequently asked
What stands out as an outlier among the largest disclosed rounds in Basel-Stadt entries shown?
Windward Bio’s disclosed $165M on 2026-05-04 is the top disclosed amount in the table and sits well above the rest; even other large disclosed rounds like Noema Pharma’s $147M (2024-12-11) and Granite Bio’s $70M (2025-04-24) do not reach it. At the low end, undisclosed amounts prevent a single “smallest disclosed” anchor, but multiple disclosed sub-$1M rounds appear such as DropGen’s $30K (2025-07-23) and databaum’s $130K (2025-12-17).
Is the funding activity clustered in a narrow date window, or spread evenly across years?
The newest rounds cluster tightly in 2026: entries run from 2026-02-17 (Axmed $6M) through 2026-06-11 (ClearideBio Therapeutics, undisclosed). The oldest row shown is FoRx Therapeutics with $10M on 2020-04-22, so the list spans 2020-04-22 to 2026-06-11 but with a clear concentration at the most recent dates.
Which sectors are over-represented relative to other categories in this Basel-Stadt list?
Biotechnology dominates the mix, appearing repeatedly across both early and later labels—for example ClearideBio Therapeutics (undisclosed, 2026-06-11), Windward Bio ($165M, 2026-05-04), Granite Bio ($70M, 2025-04-24), and Monte Rosa Therapeutics ($95M, 2021-03-12). Other categories appear less often, such as Health Care (e.g., Nuclidium $34M on 2026-05-28; Altamira Therapeutics $4M on 2024-09-17) and AI (e.g., Moonlight AI $3M on 2026-05-06; Hephaistos $190K on 2026-06-01).
How should stage information be interpreted here given missing or unclear round types?
A substantial share of rows lack a clear disclosed stage: there are multiple “Series Unknown” entries (e.g., Windward Bio is labeled Series B, but Hephaistos is “Series Unknown,” as are items like Zoundream 2026-05-05 $760K and Acthera Therapeutics 2022-12-12 undisclosed). In addition, several rows show “undisclosed” amounts (ClearideBio Therapeutics 2026-06-11, BioTara 2024-09-11, and others), and one row has a blank stage field (e.g., Nouscom 2024-03-21 $83M).
Which companies fall into the “most recent 90 days” window relative to the latest date shown (2026-06-11)?
Using a 90-day lookback from 2026-06-11, the entries beginning 2026-03-13 or later are included, such as Axmed on 2026-02-17 is outside the window but 2026-05-28 (Nuclidium $34M), 2026-05-06 (Moonlight AI $3M), 2026-05-04 (Windward Bio $165M), and 2026-06-01 (Hephaistos $190K) are inside. The recent window also includes Zoundream ($760K, 2026-05-05) and Allegria Therapeutics ($5M, 2025-12-11) is outside due to the date.
Are there notable geographic patterns within the Basel-Stadt area, or do most entries share a consistent city?
The vast majority of rows list “Basel, Basel-Stadt, Switzerland,” including Windward Bio (2026-05-04) and Noema Pharma (2024-12-11). The main intra-list geographic exception is Typewise, which is listed in Binningen, Basel-Stadt, Switzerland (Seed, undisclosed amount, 2022-09-01), while all other non-Basel city mentions are limited to that single alternative.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.